Neurocrine Biosciences | Leverandørgjeld

Trade Creditors Endring Dato
Acadia Pharmaceuticals USD 19.33M 1.79M 2024-03
Agios Pharmaceuticals USD 11.16M 1.38M 2024-03
ALKERMES USD 77.05M 9.98M 2024-03
Alnylam Pharmaceuticals USD 78.15M 22.63M 2024-03
Amgen USD 1.63B 270M 2024-03
Biogen USD 387M 16.3M 2024-03
Cytokinetics USD 12.97M 8.54M 2024-03
Dynavax Technologies USD 2.43M 2.81M 2024-03
Exelixis USD 26.07M 381K 2024-03
Gilead Sciences USD 622M 36M 2024-03
Halozyme Therapeutics USD 13.32M 1.51M 2024-03
Incyte USD 164.24M 54.64M 2024-03
Intra Cellular Therapies USD 11.53M 80K 2024-03
Ionis Pharmaceuticals USD 13.08M 12.94M 2024-03
Pfizer USD 5.59B 253M 2024-03
Prothena USD 14.42M 5.04M 2024-03
Regeneron Pharmaceuticals USD 671.3M 134.7M 2024-03
Repligen USD 18.73M 230K 2024-03
Sarepta Therapeutics USD 91.54M 3.59M 2024-03
Teva Pharmaceutical Industries USD 2.44B 163M 2024-03
Ultragenyx Pharmaceutical USD 40.97M 7.61M 2024-03
Vertex Pharmaceuticals USD 351.4M 24.5M 2024-03



Neurocrine Biosciences Leverandørgjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.